间质瘤-话题@MedSci

#间质瘤#

90篇内容 | 1462人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2193864, encodeId=868021938643d, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=原发性胃肠道间质瘤（GIST）风险评估, objectType=article, longId=817405, objectId=a76a81e40574, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393803518_4754896.jpeg, objectUrl=/article/show_article.do?id=a76a81e40574, replyNumber=0, likeNumber=7, createdTime=2024-03-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a76a81e40574, moduleTitle=原发性胃肠道间质瘤（GIST）风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a76a81e40574)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1426057, encodeId=7f19142605e0f, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=2022年NCCN指南解读：胃肠间质瘤, objectType=article, longId=737506, objectId=cf67e37506cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf67e37506cd, replyNumber=0, likeNumber=21, createdTime=2022-09-02, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf67e37506cd, moduleTitle=2022年NCCN指南解读：胃肠间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf67e37506cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426055, encodeId=0f5e14260558f, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, objectType=article, longId=735738, objectId=bcb3e35738dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcb3e35738dd, replyNumber=0, likeNumber=55, createdTime=2022-08-14, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcb3e35738dd, moduleTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcb3e35738dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426054, encodeId=5f2c1426054ab, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=如何查看【田艳涛：胃肠间质瘤指南解读2022版】的直播回放？, objectType=article, longId=732548, objectId=3401e325482d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3401e325482d, replyNumber=0, likeNumber=38, createdTime=2022-07-17, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3401e325482d, moduleTitle=如何查看【田艳涛：胃肠间质瘤指南解读2022版】的直播回放？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3401e325482d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426053, encodeId=43f3142605342, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后, objectType=article, longId=731132, objectId=d2bfe31132dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2bfe31132dd, replyNumber=0, likeNumber=47, createdTime=2022-07-04, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2bfe31132dd, moduleTitle=Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2bfe31132dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426052, encodeId=fd251426052d1, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后, objectType=article, longId=729655, objectId=e1f0e2965514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1f0e2965514, replyNumber=0, likeNumber=37, createdTime=2022-06-17, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1f0e2965514, moduleTitle=Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1f0e2965514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426051, encodeId=7758142605182, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, objectType=article, longId=729557, objectId=269be2955716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=269be2955716, replyNumber=0, likeNumber=0, createdTime=2022-06-16, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=269be2955716, moduleTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=269be2955716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426050, encodeId=d826142605048, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, objectType=article, longId=723586, objectId=f925e23586f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f925e23586f7, replyNumber=0, likeNumber=62, createdTime=2022-04-07, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f925e23586f7, moduleTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f925e23586f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426049, encodeId=34a8142604955, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Nat Rev Clin Oncol: 晚期胃肠间质瘤的治疗新策略, objectType=article, longId=301502, objectId=167130150245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=167130150245, replyNumber=0, likeNumber=50, createdTime=2022-03-25, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=167130150245, moduleTitle=Nat Rev Clin Oncol: 晚期胃肠间质瘤的治疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=167130150245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426058, encodeId=e1d31426058d5, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=【PHILIPS每日一例】胃恶性间质瘤, objectType=article, longId=289861, objectId=58c4289861ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c4289861ed, replyNumber=0, likeNumber=54, createdTime=2021-11-10, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c4289861ed, moduleTitle=【PHILIPS每日一例】胃恶性间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c4289861ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426056, encodeId=c39b142605631, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=胃肠道间质瘤的影像表现, objectType=article, longId=286584, objectId=df89286584e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df89286584e4, replyNumber=0, likeNumber=56, createdTime=2021-11-10, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df89286584e4, moduleTitle=胃肠道间质瘤的影像表现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df89286584e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426048, encodeId=afaa142604890, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效, objectType=article, longId=219181, objectId=102e219181e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=102e219181e4, replyNumber=0, likeNumber=45, createdTime=2021-10-26, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=102e219181e4, moduleTitle=Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=102e219181e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426047, encodeId=021b142604e66, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性, objectType=article, longId=217013, objectId=5eca21e01316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eca21e01316, replyNumber=0, likeNumber=41, createdTime=2021-09-14, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eca21e01316, moduleTitle=Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eca21e01316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426046, encodeId=9220142604617, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, objectType=article, longId=215316, objectId=4736215316ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4736215316ea, replyNumber=0, likeNumber=0, createdTime=2021-08-06, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4736215316ea, moduleTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4736215316ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426045, encodeId=4c1d1426045db, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=做胃镜发现胃粘膜下鼓起“小球”？警惕胃间质瘤！, objectType=article, longId=214098, objectId=b2d921409836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2d921409836, replyNumber=0, likeNumber=45, createdTime=2021-07-14, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2d921409836, moduleTitle=做胃镜发现胃粘膜下鼓起“小球”？警惕胃间质瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2d921409836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426044, encodeId=522d142604414, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle= 基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法, objectType=article, longId=209513, objectId=e01c2095131c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01c2095131c, replyNumber=0, likeNumber=48, createdTime=2021-04-05, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01c2095131c, moduleTitle= 基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01c2095131c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426043, encodeId=7278142604382, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略, objectType=article, longId=208725, objectId=3f90208e2506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f90208e2506, replyNumber=0, likeNumber=0, createdTime=2021-03-21, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f90208e2506, moduleTitle=Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f90208e2506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426042, encodeId=ef21142604228, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Eur Radiol:肿瘤表面黏膜强化征——胃肠道间质瘤的高危预测因素, objectType=article, longId=208196, objectId=2b312081966d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b312081966d, replyNumber=0, likeNumber=36, createdTime=2021-03-10, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b312081966d, moduleTitle=Eur Radiol:肿瘤表面黏膜强化征——胃肠道间质瘤的高危预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b312081966d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426041, encodeId=757714260413b, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=Int J Cancer：新辅助系统疗法对胃肠道间质瘤预后的影响, objectType=article, longId=207840, objectId=b2a020e84011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a020e84011, replyNumber=0, likeNumber=65, createdTime=2021-03-04, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a020e84011, moduleTitle=Int J Cancer：新辅助系统疗法对胃肠道间质瘤预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a020e84011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426040, encodeId=c9191426040eb, content=<a href='/topic/show?id=02fe9e30227' target=_blank style='color:#2F92EE;'>#间质瘤#</a>, objectTitle=胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”, objectType=article, longId=207384, objectId=922f20e38487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922f20e38487, replyNumber=0, likeNumber=42, createdTime=2021-02-22, rootId=0, userName=zhty5338, userId=7ede4029724, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922f20e38487, moduleTitle=胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922f20e38487)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

间质瘤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#间质瘤#

原发性胃肠道间质瘤（GIST）风险评估

2024-03-18发表于上海

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

2022年NCCN指南解读：胃肠间质瘤

2022-09-02

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤

2022-08-14

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

如何查看【田艳涛：胃肠间质瘤指南解读2022版】的直播回放？

2022-07-17

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后

2022-07-04

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后

2022-06-17

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后

2022-06-16

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）

2022-04-07

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Nat Rev Clin Oncol: 晚期胃肠间质瘤的治疗新策略

2022-03-25

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

【PHILIPS每日一例】胃恶性间质瘤

2021-11-10

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

胃肠道间质瘤的影像表现

2021-11-10

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效

2021-10-26

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性

2021-09-14

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究

2021-08-06

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

做胃镜发现胃粘膜下鼓起“小球”？警惕胃间质瘤！

2021-07-14

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法

2021-04-05

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略

2021-03-21

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

Eur Radiol:肿瘤表面黏膜强化征——胃肠道间质瘤的高危预测因素

2021-03-10

heli0118 (审核中...)

前往app查看评论内容

#间质瘤#

Int J Cancer：新辅助系统疗法对胃肠道间质瘤预后的影响

2021-03-04

zhty5338 (审核中...)

前往app查看评论内容

#间质瘤#

胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”

2021-02-22

科室
- - 订阅+
  - 更多科室
工具
服务